127 related articles for article (PubMed ID: 14755937)
1. [Oral disintegrating tablets. A new, modern, solid dosage form].
Popa G; Gafiţanu E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):337-42. PubMed ID: 14755937
[TBL] [Abstract][Full Text] [Related]
2. [Orally disintegrating tablets--advantages and drawbacks].
Tho I
Tidsskr Nor Laegeforen; 2012 Feb; 132(4):424-5. PubMed ID: 22353836
[TBL] [Abstract][Full Text] [Related]
3. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
Stoltenberg I; Breitkreutz J
Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
[TBL] [Abstract][Full Text] [Related]
4. [Research progress on the oral solid rapidly disintegrating dosage form].
Shen L; Lin X; Xu DS; Feng Y
Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):89-92. PubMed ID: 15714807
[TBL] [Abstract][Full Text] [Related]
5. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT.
Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñe-Negre JM; Miñarro M; Ticó JR
Eur J Pharm Biopharm; 2009 Nov; 73(3):414-23. PubMed ID: 19602435
[TBL] [Abstract][Full Text] [Related]
6. Dissolution testing of orally disintegrating tablets.
Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
[TBL] [Abstract][Full Text] [Related]
7. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation.
Laitinen R; Suihko E; Bjorkqvist M; Riikonen J; Lehto VP; Jarvinen K; Ketolainen J
Drug Dev Ind Pharm; 2010 May; 36(5):601-13. PubMed ID: 19954406
[TBL] [Abstract][Full Text] [Related]
8. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
Comoglu T; Dilek Ozyilmaz E
Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
[TBL] [Abstract][Full Text] [Related]
9. Obtaining fast dissolving disintegrating tablets with different doses of melatonin.
Muñoz H; Castan H; Clares B; Ruiz MA
Int J Pharm; 2014 Jun; 467(1-2):84-9. PubMed ID: 24699354
[TBL] [Abstract][Full Text] [Related]
10. New oral solid dosage form for furosemide oral administration.
Perioli L; D'Alba G; Pagano C
Eur J Pharm Biopharm; 2012 Apr; 80(3):621-9. PubMed ID: 22230797
[TBL] [Abstract][Full Text] [Related]
11. The technologies used for developing orally disintegrating tablets: a review.
Badgujar BP; Mundada AS
Acta Pharm; 2011 Jun; 61(2):117-39. PubMed ID: 21684842
[TBL] [Abstract][Full Text] [Related]
12. Recent Formulation Advances and Preparation of Orally Disintegrating Tablets.
Ejeta F
Int J Pharm Compd; 2022; 26(5):370-377. PubMed ID: 36053763
[TBL] [Abstract][Full Text] [Related]
13. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of mouth dissolving tablets of the Etoricoxib.
Chandira RM; Venkataeswarlu BS; Kumudhavalli MV; Debjitbhowmik ; Jayakar B
Pak J Pharm Sci; 2010 Apr; 23(2):178-81. PubMed ID: 20363696
[TBL] [Abstract][Full Text] [Related]
15. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
16. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
17. Orally disintegrating systems: innovations in formulation and technology.
Goel H; Rai P; Rana V; Tiwary AK
Recent Pat Drug Deliv Formul; 2008; 2(3):258-74. PubMed ID: 19075912
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
Liu F; Ghaffur A; Bains J; Hamdy S
Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
[TBL] [Abstract][Full Text] [Related]
19. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
Preis M
AAPS PharmSciTech; 2015 Apr; 16(2):234-41. PubMed ID: 25739913
[TBL] [Abstract][Full Text] [Related]
20. Taste masking microspheres for orally disintegrating tablets.
Xu J; Bovet LL; Zhao K
Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
